ArticleFIBROBLAST GROWTH FACTOR 23 AND CAROTID ARTERY INTIMAL MEDIUM THICKNESS IN CHILDREN WITH CHRONIC KIDNEY DISEASE
ArticleFIBROBLAST GROWTH FACTOR 23 AND CAROTID ARTERY INTIMAL MEDIUM THICKNESS IN CHILDREN WITH CHRONIC KIDNEY DISEASE
ArticleFibroblast growth factor-23 is independently associated with the left ventricular mass index in hemodialysis patients
ArticleFibroblast growth factor-23 is independently associated with the left ventricular mass index in hemodialysis patients
ArticleSerum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients
ArticleSerum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients
ArticleSerum Fibroblast Growth Factor 23 as an Early Biomarker for Detection of Renal Osteodystrophy and Progression of Chronic Kidney Disease in Children
ArticleSerum Fibroblast Growth Factor 23 as an Early Biomarker for Detection of Renal Osteodystrophy and Progression of Chronic Kidney Disease in Children
ArticleThe relation between fibroblast growth factor 23 level and anemia in chronic kidney disease patients.
ArticleThe relation between fibroblast growth factor 23 level and anemia in chronic kidney disease patients.
ArticleThe Effect of High Flux versus Low Flux Dialyzers on Serum Fibroblast Growth Factor-23 (FGF-23) and Its Cardiovascular Implications in Prevalent Hemodialysis Patients
ArticleThe Effect of High Flux versus Low Flux Dialyzers on Serum Fibroblast Growth Factor-23 (FGF-23) and Its Cardiovascular Implications in Prevalent Hemodialysis Patients
ArticleFibroblasts Growth Factor 23 (FGF23) Level and its Correlation with Serum Calcium, Phosphorus, and Ferritin Level in Adult b-Thalassemia Patients: Single Center Study
ArticleFibroblasts Growth Factor 23 (FGF23) Level and its Correlation with Serum Calcium, Phosphorus, and Ferritin Level in Adult b-Thalassemia Patients: Single Center Study
ArticleSTUDY OF SERUM OSTEOINDUCTIVE FACTOR AS AN EARLY MARKER OF NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETIS
ArticleSTUDY OF SERUM OSTEOINDUCTIVE FACTOR AS AN EARLY MARKER OF NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETIS
ArticleFibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients
ArticleFibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients
ArticleSerum Level of Fibroblast Growth Factor 23 in Patients with Uremic Pruritus Undergoing Hemodialysis
ArticleSerum Level of Fibroblast Growth Factor 23 in Patients with Uremic Pruritus Undergoing Hemodialysis